Carbon Monoxide to Prevent Lung Inflammation

NCT00094406 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

NIH

Sponsor class

Conditions

Respiratory Distress Syndrome, Adult

Interventions

PROCEDURE: Bronchoscopy
PROCEDURE: Bronchoalveolar lavage
DRUG: Endotoxin
DRUG: Carbon Monoxide

Sponsor

National Institutes of Health Clinical Center (CC)